Maria Hackett
DecImmune Therapeutics (United States)(US)
Publications by Year
Research Areas
Cell death mechanisms and regulation, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, interferon and immune responses, MicroRNA in disease regulation
Most-Cited Works
- → Substrate Specificities of Caspase Family Proteases(1997)879 cited
- → Inhibition of ICE Family Proteases by Baculovirus Antiapoptotic Protein p35(1995)642 cited
- → Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer(1994)569 cited
- → A single-molecule method for the quantitation of microRNA gene expression(2005)282 cited
- → Identification and Characterization of ICH-2, a Novel Member of the Interleukin-1β-converting Enzyme Family of Cysteine Proteases(1995)263 cited
- → Regulation of Protein Phosphatase 2A Activity by Caspase-3 during Apoptosis(1998)152 cited
- → Stability and Oligomeric Equilibria of Refolded Interleukin-1β Converting Enzyme(1996)41 cited
- → Preparation of an Autolysis-Resistant Interleukin-1β Converting Enzyme Mutant(1996)19 cited
- → 1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors(2023)1 cited
- → Abstract 2369: EVOLVE-105, a differentiated CD20-targeted CD2 co-stimulatory T cell engager engineered for the treatment of B cell malignancies(2024)